
Keywords: اتانولامین اولئات; AE; adverse event; BRTO; balloon-occluded retrograde transvenous obliteration; CAC; Central Adjudication Committee; CARTO; coil-assisted retrograde transvenous obliteration; EO; ethanolamine oleate; EV; esophageal varix; FAS; full analysis set; GRS; gastr